APO Research
Talk to an analyst

APO RESEARCH · REPORT

Molecular Diagnostics Tests & Reagents

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Molecular Diagnostics Tests & Reagents Market Analysis and Forecast 2026-2032

19 December 2025219 pages

Choose your research edition.

Industry ResearchMolecular Diagnostics Tests & Reagents Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Molecular Diagnostics Tests & Reagents Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Molecular Diagnostics Tests & Reagents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molecular Diagnostics Tests & Reagents Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Molecular Diagnostics Tests & Reagents Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Molecular Diagnostics Tests & Reagents market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Molecular Diagnostics Tests & Reagents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Molecular Diagnostics Tests & Reagents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Molecular Diagnostics Tests & Reagents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Molecular Diagnostics Tests & Reagents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Molecular Diagnostics Tests & Reagents include Abbott Laboratories, Shanghai Kehua Bio-engineering, Johnson and Johnson, Merck Millipore, Beijing Leadman Biochemistry, Thermo Scientific, Sysmex Corporation, Siemens Healthcare and Roche Diagnostics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Molecular Diagnostics Tests & Reagents, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Molecular Diagnostics Tests & Reagents, also provides the revenue of main regions and countries. Of the upcoming market potential for Molecular Diagnostics Tests & Reagents, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Molecular Diagnostics Tests & Reagents revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Molecular Diagnostics Tests & Reagents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Molecular Diagnostics Tests & Reagents revenue, projected growth trends, production technology, application and end-user industry.

Molecular Diagnostics Tests & Reagents Segment by Company

Abbott Laboratories

Shanghai Kehua Bio-engineering

Johnson and Johnson

Merck Millipore

Beijing Leadman Biochemistry

Thermo Scientific

Sysmex Corporation

Siemens Healthcare

Roche Diagnostics

Ortho Clinical Diagnostics

Mindray

Danaher Corporation

DAAN Gene

Cobas

Caprion

BioSino Bio-technology

Bio-Rad Laboratories

Biomerieux

Becton Dickinson

Beckman Coulter Inc

Aptiv Solution

Molecular Diagnostics Tests & Reagents Segment by Type

Professional Diagnostic

Diabetes Monitoring

Molecular Diagnostic

Molecular Diagnostics Tests & Reagents Segment by Application

HIV

Infectious Diseases

Diabetes

Cardiology

Oncology

Other

Molecular Diagnostics Tests & Reagents Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Diagnostics Tests & Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Diagnostics Tests & Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Diagnostics Tests & Reagents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Molecular Diagnostics Tests & Reagents in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Molecular Diagnostics Tests & Reagents company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Diagnostics Tests & Reagents revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Molecular Diagnostics Tests & Reagents Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Professional Diagnostic Major Player Table 3. Diabetes Monitoring Major Player Table 4. Molecular Diagnostic Major Player Table 5. Global Molecular Diagnostics Tests & Reagents Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. HIV Major Player Table 7. Infectious Diseases Major Player Table 8. Diabetes Major Player Table 9. Cardiology Major Player Table 10. Oncology Major Player Table 11. Other Major Player Table 12. Molecular Diagnostics Tests & Reagents Industry Trends Table 13. Molecular Diagnostics Tests & Reagents Industry Drivers Table 14. Molecular Diagnostics Tests & Reagents Industry Opportunities and Challenges Table 15. Molecular Diagnostics Tests & Reagents Industry Restraints Table 16. Global Molecular Diagnostics Tests & Reagents Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Molecular Diagnostics Tests & Reagents Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Molecular Diagnostics Tests & Reagents Market Share by Region (2021-2026) Table 19. Global Molecular Diagnostics Tests & Reagents Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Molecular Diagnostics Tests & Reagents Market Share by Region (2027-2032) Table 21. Global Molecular Diagnostics Tests & Reagents Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Players (2021-2026) Table 23. Global Molecular Diagnostics Tests & Reagents Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Molecular Diagnostics Tests & Reagents Key Players Headquarters & Area Served Table 25. Global Molecular Diagnostics Tests & Reagents Players, Product Type & Application Table 26. Global Molecular Diagnostics Tests & Reagents Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Molecular Diagnostics Tests & Reagents by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Molecular Diagnostics Tests & Reagents Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Molecular Diagnostics Tests & Reagents Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Type (2021-2026) Table 33. Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Type (2027-2032) Table 34. Global Molecular Diagnostics Tests & Reagents Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Molecular Diagnostics Tests & Reagents Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Application (2021-2026) Table 38. Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Application (2027-2032) Table 39. Abbott Laboratories Company Information Table 40. Abbott Laboratories Business Overview Table 41. Abbott Laboratories Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Abbott Laboratories Molecular Diagnostics Tests & Reagents Product Portfolio Table 43. Abbott Laboratories Recent Development Table 44. Shanghai Kehua Bio-engineering Company Information Table 45. Shanghai Kehua Bio-engineering Business Overview Table 46. Shanghai Kehua Bio-engineering Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Shanghai Kehua Bio-engineering Molecular Diagnostics Tests & Reagents Product Portfolio Table 48. Shanghai Kehua Bio-engineering Recent Development Table 49. Johnson and Johnson Company Information Table 50. Johnson and Johnson Business Overview Table 51. Johnson and Johnson Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Johnson and Johnson Molecular Diagnostics Tests & Reagents Product Portfolio Table 53. Johnson and Johnson Recent Development Table 54. Merck Millipore Company Information Table 55. Merck Millipore Business Overview Table 56. Merck Millipore Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Merck Millipore Molecular Diagnostics Tests & Reagents Product Portfolio Table 58. Merck Millipore Recent Development Table 59. Beijing Leadman Biochemistry Company Information Table 60. Beijing Leadman Biochemistry Business Overview Table 61. Beijing Leadman Biochemistry Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Beijing Leadman Biochemistry Molecular Diagnostics Tests & Reagents Product Portfolio Table 63. Beijing Leadman Biochemistry Recent Development Table 64. Thermo Scientific Company Information Table 65. Thermo Scientific Business Overview Table 66. Thermo Scientific Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Thermo Scientific Molecular Diagnostics Tests & Reagents Product Portfolio Table 68. Thermo Scientific Recent Development Table 69. Sysmex Corporation Company Information Table 70. Sysmex Corporation Business Overview Table 71. Sysmex Corporation Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Sysmex Corporation Molecular Diagnostics Tests & Reagents Product Portfolio Table 73. Sysmex Corporation Recent Development Table 74. Siemens Healthcare Company Information Table 75. Siemens Healthcare Business Overview Table 76. Siemens Healthcare Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Siemens Healthcare Molecular Diagnostics Tests & Reagents Product Portfolio Table 78. Siemens Healthcare Recent Development Table 79. Roche Diagnostics Company Information Table 80. Roche Diagnostics Business Overview Table 81. Roche Diagnostics Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Roche Diagnostics Molecular Diagnostics Tests & Reagents Product Portfolio Table 83. Roche Diagnostics Recent Development Table 84. Ortho Clinical Diagnostics Company Information Table 85. Ortho Clinical Diagnostics Business Overview Table 86. Ortho Clinical Diagnostics Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Ortho Clinical Diagnostics Molecular Diagnostics Tests & Reagents Product Portfolio Table 88. Ortho Clinical Diagnostics Recent Development Table 89. Mindray Company Information Table 90. Mindray Business Overview Table 91. Mindray Molecular Diagnostics Tests & Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Mindray Molecular Diagnostics Tests & Reagents Product Portfolio Table 93. Mindray Recent Development Table 94. Danaher Corporation Company Information Table 95. Danaher Corporation Business Overview Table 96. Danaher Corporation Molecular Diagnostics Tests & Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Danaher Corporation Molecular Diagnostics Tests & Reagents Product Portfolio Table 98. Danaher Corporation Recent Development Table 99. DAAN Gene Company Information Table 100. DAAN Gene Business Overview Table 101. DAAN Gene Molecular Diagnostics Tests & Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. DAAN Gene Molecular Diagnostics Tests & Reagents Product Portfolio Table 103. DAAN Gene Recent Development Table 104. Cobas Company Information Table 105. Cobas Business Overview Table 106. Cobas Molecular Diagnostics Tests & Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Cobas Molecular Diagnostics Tests & Reagents Product Portfolio Table 108. Cobas Recent Development Table 109. Caprion Company Information Table 110. Caprion Business Overview Table 111. Caprion Molecular Diagnostics Tests & Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Caprion Molecular Diagnostics Tests & Reagents Product Portfolio Table 113. Caprion Recent Development Table 114. BioSino Bio-technology Company Information Table 115. BioSino Bio-technology Business Overview Table 116. BioSino Bio-technology Molecular Diagnostics Tests & Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. BioSino Bio-technology Molecular Diagnostics Tests & Reagents Product Portfolio Table 118. BioSino Bio-technology Recent Development Table 119. Bio-Rad Laboratories Company Information Table 120. Bio-Rad Laboratories Business Overview Table 121. Bio-Rad Laboratories Molecular Diagnostics Tests & Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Bio-Rad Laboratories Molecular Diagnostics Tests & Reagents Product Portfolio Table 123. Bio-Rad Laboratories Recent Development Table 124. Biomerieux Company Information Table 125. Biomerieux Business Overview Table 126. Biomerieux Molecular Diagnostics Tests & Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Biomerieux Molecular Diagnostics Tests & Reagents Product Portfolio Table 128. Biomerieux Recent Development Table 129. Becton Dickinson Company Information Table 130. Becton Dickinson Business Overview Table 131. Becton Dickinson Molecular Diagnostics Tests & Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Becton Dickinson Molecular Diagnostics Tests & Reagents Product Portfolio Table 133. Becton Dickinson Recent Development Table 134. Beckman Coulter Inc Company Information Table 135. Beckman Coulter Inc Business Overview Table 136. Beckman Coulter Inc Molecular Diagnostics Tests & Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Beckman Coulter Inc Molecular Diagnostics Tests & Reagents Product Portfolio Table 138. Beckman Coulter Inc Recent Development Table 139. Aptiv Solution Company Information Table 140. Aptiv Solution Business Overview Table 141. Aptiv Solution Molecular Diagnostics Tests & Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Aptiv Solution Molecular Diagnostics Tests & Reagents Product Portfolio Table 143. Aptiv Solution Recent Development Table 144. North America Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2026) & (US$ Million) Table 145. North America Molecular Diagnostics Tests & Reagents Revenue by Type (2027-2032) & (US$ Million) Table 146. North America Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2026) & (US$ Million) Table 147. North America Molecular Diagnostics Tests & Reagents Revenue by Application (2027-2032) & (US$ Million) Table 148. North America Molecular Diagnostics Tests & Reagents Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. North America Molecular Diagnostics Tests & Reagents Revenue by Country (2021-2026) & (US$ Million) Table 150. North America Molecular Diagnostics Tests & Reagents Revenue by Country (US$ Million) & (2027-2032) Table 151. Europe Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2026) & (US$ Million) Table 152. Europe Molecular Diagnostics Tests & Reagents Revenue by Type (2027-2032) & (US$ Million) Table 153. Europe Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2026) & (US$ Million) Table 154. Europe Molecular Diagnostics Tests & Reagents Revenue by Application (2027-2032) & (US$ Million) Table 155. Europe Molecular Diagnostics Tests & Reagents Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Europe Molecular Diagnostics Tests & Reagents Revenue by Country (2021-2026) & (US$ Million) Table 157. Europe Molecular Diagnostics Tests & Reagents Revenue by Country (US$ Million) & (2027-2032) Table 158. China Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2026) & (US$ Million) Table 159. China Molecular Diagnostics Tests & Reagents Revenue by Type (2027-2032) & (US$ Million) Table 160. China Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2026) & (US$ Million) Table 161. China Molecular Diagnostics Tests & Reagents Revenue by Application (2027-2032) & (US$ Million) Table 162. Asia Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2026) & (US$ Million) Table 163. Asia Molecular Diagnostics Tests & Reagents Revenue by Type (2027-2032) & (US$ Million) Table 164. Asia Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2026) & (US$ Million) Table 165. Asia Molecular Diagnostics Tests & Reagents Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia Molecular Diagnostics Tests & Reagents Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 167. Asia Molecular Diagnostics Tests & Reagents Revenue by Region (US$ Million) & (2021-2026) Table 168. Asia Molecular Diagnostics Tests & Reagents Revenue by Region (US$ Million) & (2027-2032) Table 169. SAMEA Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2026) & (US$ Million) Table 170. SAMEA Molecular Diagnostics Tests & Reagents Revenue by Type (2027-2032) & (US$ Million) Table 171. SAMEA Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2026) & (US$ Million) Table 172. SAMEA Molecular Diagnostics Tests & Reagents Revenue by Application (2027-2032) & (US$ Million) Table 173. SAMEA Molecular Diagnostics Tests & Reagents Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. SAMEA Molecular Diagnostics Tests & Reagents Revenue by Country (2021-2026) & (US$ Million) Table 175. SAMEA Molecular Diagnostics Tests & Reagents Revenue by Country (US$ Million) & (2027-2032) Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Molecular Diagnostics Tests & Reagents Image Figure 2. Global Molecular Diagnostics Tests & Reagents Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molecular Diagnostics Tests & Reagents Market Size Share 2021 VS 2025 VS 2032 Figure 4. Professional Diagnostic Image Figure 5. Diabetes Monitoring Image Figure 6. Molecular Diagnostic Image Figure 7. Global Molecular Diagnostics Tests & Reagents Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Molecular Diagnostics Tests & Reagents Market Size Share 2021 VS 2025 VS 2032 Figure 9. HIV Image Figure 10. Infectious Diseases Image Figure 11. Diabetes Image Figure 12. Cardiology Image Figure 13. Oncology Image Figure 14. Other Image Figure 15. Global Molecular Diagnostics Tests & Reagents Market Size (US$ Million) & (2021-2032) Figure 16. Global Molecular Diagnostics Tests & Reagents Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Molecular Diagnostics Tests & Reagents Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Molecular Diagnostics Tests & Reagents Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Molecular Diagnostics Tests & Reagents Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Molecular Diagnostics Tests & Reagents Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Type (2021-2032) Figure 23. Global Molecular Diagnostics Tests & Reagents Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Application (2021-2032) Figure 26. North America Molecular Diagnostics Tests & Reagents Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Molecular Diagnostics Tests & Reagents Revenue Share by Type (2021-2032) Figure 28. North America Molecular Diagnostics Tests & Reagents Revenue Share by Application (2021-2032) Figure 29. North America Molecular Diagnostics Tests & Reagents Revenue Share by Country (2021-2032) Figure 30. United States Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Molecular Diagnostics Tests & Reagents Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Molecular Diagnostics Tests & Reagents Revenue Share by Type (2021-2032) Figure 35. Europe Molecular Diagnostics Tests & Reagents Revenue Share by Application (2021-2032) Figure 36. Europe Molecular Diagnostics Tests & Reagents Revenue Share by Country (2021-2032) Figure 37. Germany Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Molecular Diagnostics Tests & Reagents Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Molecular Diagnostics Tests & Reagents Revenue Share by Type (2021-2032) Figure 47. China Molecular Diagnostics Tests & Reagents Revenue Share by Application (2021-2032) Figure 48. Asia Molecular Diagnostics Tests & Reagents Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Molecular Diagnostics Tests & Reagents Revenue Share by Type (2021-2032) Figure 50. Asia Molecular Diagnostics Tests & Reagents Revenue Share by Application (2021-2032) Figure 51. Asia Molecular Diagnostics Tests & Reagents Revenue Share by Region (2021-2032) Figure 52. Japan Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Molecular Diagnostics Tests & Reagents Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Molecular Diagnostics Tests & Reagents Revenue Share by Type (2021-2032) Figure 60. SAMEA Molecular Diagnostics Tests & Reagents Revenue Share by Application (2021-2032) Figure 61. SAMEA Molecular Diagnostics Tests & Reagents Revenue Share by Country (2021-2032) Figure 62. Brazil Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Molecular Diagnostics Tests & Reagents Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Professional Diagnostic
  • Diabetes Monitoring
  • Molecular Diagnostic
Applications
  • HIV
  • Infectious Diseases
  • Diabetes
  • Cardiology
  • Oncology
  • Other
Companies covered
  • Abbott Laboratories
  • Shanghai Kehua Bio-engineering
  • Johnson and Johnson
  • Merck Millipore
  • Beijing Leadman Biochemistry
  • Thermo Scientific
  • Sysmex Corporation
  • Siemens Healthcare
  • Roche Diagnostics
  • Ortho Clinical Diagnostics
  • Mindray
  • Danaher Corporation
  • DAAN Gene
  • Cobas
  • Caprion
  • BioSino Bio-technology
  • Bio-Rad Laboratories
  • Biomerieux
  • Becton Dickinson
  • Beckman Coulter Inc
  • Aptiv Solution

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Molecular Diagnostics Tests & Reagents Market by Type
  3. 1.2.1 Global Molecular Diagnostics Tests & Reagents Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Professional Diagnostic
  5. 1.2.3 Diabetes Monitoring
  6. 1.2.4 Molecular Diagnostic
  7. 1.3 Molecular Diagnostics Tests & Reagents Market by Application
  8. 1.3.1 Global Molecular Diagnostics Tests & Reagents Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 HIV
  10. 1.3.3 Infectious Diseases
  11. 1.3.4 Diabetes
  12. 1.3.5 Cardiology
  13. 1.3.6 Oncology
  14. 1.3.7 Other
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Molecular Diagnostics Tests & Reagents Market Dynamics
  1. 2.1 Molecular Diagnostics Tests & Reagents Industry Trends
  2. 2.2 Molecular Diagnostics Tests & Reagents Industry Drivers
  3. 2.3 Molecular Diagnostics Tests & Reagents Industry Opportunities and Challenges
  4. 2.4 Molecular Diagnostics Tests & Reagents Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Molecular Diagnostics Tests & Reagents Market Perspective (2021-2032)
  2. 3.2 Global Molecular Diagnostics Tests & Reagents Growth Trends by Region
  3. 3.2.1 Global Molecular Diagnostics Tests & Reagents Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Molecular Diagnostics Tests & Reagents Market Size by Region (2021-2026)
  5. 3.2.3 Global Molecular Diagnostics Tests & Reagents Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Molecular Diagnostics Tests & Reagents Revenue by Players
  2. 4.1.1 Global Molecular Diagnostics Tests & Reagents Revenue by Players (2021-2026)
  3. 4.1.2 Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Molecular Diagnostics Tests & Reagents Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Molecular Diagnostics Tests & Reagents Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Molecular Diagnostics Tests & Reagents Key Players Headquarters & Area Served
  7. 4.4 Global Molecular Diagnostics Tests & Reagents Players, Product Type & Application
  8. 4.5 Global Molecular Diagnostics Tests & Reagents Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Molecular Diagnostics Tests & Reagents Market CR5 and HHI
  11. 4.6.3 2025 Molecular Diagnostics Tests & Reagents Tier 1, Tier 2, and Tier 3
5 Molecular Diagnostics Tests & Reagents Market Size by Type
  1. 5.1 Global Molecular Diagnostics Tests & Reagents Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2032)
  3. 5.3 Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Type (2021-2032)
6 Molecular Diagnostics Tests & Reagents Market Size by Application
  1. 6.1 Global Molecular Diagnostics Tests & Reagents Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2032)
  3. 6.3 Global Molecular Diagnostics Tests & Reagents Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott Laboratories
  2. 7.1.1 Abbott Laboratories Company Information
  3. 7.1.2 Abbott Laboratories Business Overview
  4. 7.1.3 Abbott Laboratories Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Laboratories Molecular Diagnostics Tests & Reagents Product Portfolio
  6. 7.1.5 Abbott Laboratories Recent Developments
  7. 7.2 Shanghai Kehua Bio-engineering
  8. 7.2.1 Shanghai Kehua Bio-engineering Company Information
  9. 7.2.2 Shanghai Kehua Bio-engineering Business Overview
  10. 7.2.3 Shanghai Kehua Bio-engineering Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Shanghai Kehua Bio-engineering Molecular Diagnostics Tests & Reagents Product Portfolio
  12. 7.2.5 Shanghai Kehua Bio-engineering Recent Developments
  13. 7.3 Johnson and Johnson
  14. 7.3.1 Johnson and Johnson Company Information
  15. 7.3.2 Johnson and Johnson Business Overview
  16. 7.3.3 Johnson and Johnson Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Johnson and Johnson Molecular Diagnostics Tests & Reagents Product Portfolio
  18. 7.3.5 Johnson and Johnson Recent Developments
  19. 7.4 Merck Millipore
  20. 7.4.1 Merck Millipore Company Information
  21. 7.4.2 Merck Millipore Business Overview
  22. 7.4.3 Merck Millipore Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Merck Millipore Molecular Diagnostics Tests & Reagents Product Portfolio
  24. 7.4.5 Merck Millipore Recent Developments
  25. 7.5 Beijing Leadman Biochemistry
  26. 7.5.1 Beijing Leadman Biochemistry Company Information
  27. 7.5.2 Beijing Leadman Biochemistry Business Overview
  28. 7.5.3 Beijing Leadman Biochemistry Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Beijing Leadman Biochemistry Molecular Diagnostics Tests & Reagents Product Portfolio
  30. 7.5.5 Beijing Leadman Biochemistry Recent Developments
  31. 7.6 Thermo Scientific
  32. 7.6.1 Thermo Scientific Company Information
  33. 7.6.2 Thermo Scientific Business Overview
  34. 7.6.3 Thermo Scientific Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Thermo Scientific Molecular Diagnostics Tests & Reagents Product Portfolio
  36. 7.6.5 Thermo Scientific Recent Developments
  37. 7.7 Sysmex Corporation
  38. 7.7.1 Sysmex Corporation Company Information
  39. 7.7.2 Sysmex Corporation Business Overview
  40. 7.7.3 Sysmex Corporation Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sysmex Corporation Molecular Diagnostics Tests & Reagents Product Portfolio
  42. 7.7.5 Sysmex Corporation Recent Developments
  43. 7.8 Siemens Healthcare
  44. 7.8.1 Siemens Healthcare Company Information
  45. 7.8.2 Siemens Healthcare Business Overview
  46. 7.8.3 Siemens Healthcare Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Siemens Healthcare Molecular Diagnostics Tests & Reagents Product Portfolio
  48. 7.8.5 Siemens Healthcare Recent Developments
  49. 7.9 Roche Diagnostics
  50. 7.9.1 Roche Diagnostics Company Information
  51. 7.9.2 Roche Diagnostics Business Overview
  52. 7.9.3 Roche Diagnostics Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Roche Diagnostics Molecular Diagnostics Tests & Reagents Product Portfolio
  54. 7.9.5 Roche Diagnostics Recent Developments
  55. 7.10 Ortho Clinical Diagnostics
  56. 7.10.1 Ortho Clinical Diagnostics Company Information
  57. 7.10.2 Ortho Clinical Diagnostics Business Overview
  58. 7.10.3 Ortho Clinical Diagnostics Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Ortho Clinical Diagnostics Molecular Diagnostics Tests & Reagents Product Portfolio
  60. 7.10.5 Ortho Clinical Diagnostics Recent Developments
  61. 7.11 Mindray
  62. 7.11.1 Mindray Company Information
  63. 7.11.2 Mindray Business Overview
  64. 7.11.3 Mindray Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Mindray Molecular Diagnostics Tests & Reagents Product Portfolio
  66. 7.11.5 Mindray Recent Developments
  67. 7.12 Danaher Corporation
  68. 7.12.1 Danaher Corporation Company Information
  69. 7.12.2 Danaher Corporation Business Overview
  70. 7.12.3 Danaher Corporation Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Danaher Corporation Molecular Diagnostics Tests & Reagents Product Portfolio
  72. 7.12.5 Danaher Corporation Recent Developments
  73. 7.13 DAAN Gene
  74. 7.13.1 DAAN Gene Company Information
  75. 7.13.2 DAAN Gene Business Overview
  76. 7.13.3 DAAN Gene Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  77. 7.13.4 DAAN Gene Molecular Diagnostics Tests & Reagents Product Portfolio
  78. 7.13.5 DAAN Gene Recent Developments
  79. 7.14 Cobas
  80. 7.14.1 Cobas Company Information
  81. 7.14.2 Cobas Business Overview
  82. 7.14.3 Cobas Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Cobas Molecular Diagnostics Tests & Reagents Product Portfolio
  84. 7.14.5 Cobas Recent Developments
  85. 7.15 Caprion
  86. 7.15.1 Caprion Company Information
  87. 7.15.2 Caprion Business Overview
  88. 7.15.3 Caprion Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Caprion Molecular Diagnostics Tests & Reagents Product Portfolio
  90. 7.15.5 Caprion Recent Developments
  91. 7.16 BioSino Bio-technology
  92. 7.16.1 BioSino Bio-technology Company Information
  93. 7.16.2 BioSino Bio-technology Business Overview
  94. 7.16.3 BioSino Bio-technology Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  95. 7.16.4 BioSino Bio-technology Molecular Diagnostics Tests & Reagents Product Portfolio
  96. 7.16.5 BioSino Bio-technology Recent Developments
  97. 7.17 Bio-Rad Laboratories
  98. 7.17.1 Bio-Rad Laboratories Company Information
  99. 7.17.2 Bio-Rad Laboratories Business Overview
  100. 7.17.3 Bio-Rad Laboratories Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Bio-Rad Laboratories Molecular Diagnostics Tests & Reagents Product Portfolio
  102. 7.17.5 Bio-Rad Laboratories Recent Developments
  103. 7.18 Biomerieux
  104. 7.18.1 Biomerieux Company Information
  105. 7.18.2 Biomerieux Business Overview
  106. 7.18.3 Biomerieux Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Biomerieux Molecular Diagnostics Tests & Reagents Product Portfolio
  108. 7.18.5 Biomerieux Recent Developments
  109. 7.19 Becton Dickinson
  110. 7.19.1 Becton Dickinson Company Information
  111. 7.19.2 Becton Dickinson Business Overview
  112. 7.19.3 Becton Dickinson Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Becton Dickinson Molecular Diagnostics Tests & Reagents Product Portfolio
  114. 7.19.5 Becton Dickinson Recent Developments
  115. 7.20 Beckman Coulter Inc
  116. 7.20.1 Beckman Coulter Inc Company Information
  117. 7.20.2 Beckman Coulter Inc Business Overview
  118. 7.20.3 Beckman Coulter Inc Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Beckman Coulter Inc Molecular Diagnostics Tests & Reagents Product Portfolio
  120. 7.20.5 Beckman Coulter Inc Recent Developments
  121. 7.21 Aptiv Solution
  122. 7.21.1 Aptiv Solution Company Information
  123. 7.21.2 Aptiv Solution Business Overview
  124. 7.21.3 Aptiv Solution Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Aptiv Solution Molecular Diagnostics Tests & Reagents Product Portfolio
  126. 7.21.5 Aptiv Solution Recent Developments
8 North America
  1. 8.1 North America Molecular Diagnostics Tests & Reagents Revenue (2021-2032)
  2. 8.2 North America Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2032)
  3. 8.2.1 North America Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2026)
  4. 8.2.2 North America Molecular Diagnostics Tests & Reagents Revenue by Type (2027-2032)
  5. 8.3 North America Molecular Diagnostics Tests & Reagents Revenue Share by Type (2021-2032)
  6. 8.4 North America Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2032)
  7. 8.4.1 North America Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2026)
  8. 8.4.2 North America Molecular Diagnostics Tests & Reagents Revenue by Application (2027-2032)
  9. 8.5 North America Molecular Diagnostics Tests & Reagents Revenue Share by Application (2021-2032)
  10. 8.6 North America Molecular Diagnostics Tests & Reagents Revenue by Country
  11. 8.6.1 North America Molecular Diagnostics Tests & Reagents Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Molecular Diagnostics Tests & Reagents Revenue by Country (2021-2026)
  13. 8.6.3 North America Molecular Diagnostics Tests & Reagents Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Molecular Diagnostics Tests & Reagents Revenue (2021-2032)
  2. 9.2 Europe Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2032)
  3. 9.2.1 Europe Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2026)
  4. 9.2.2 Europe Molecular Diagnostics Tests & Reagents Revenue by Type (2027-2032)
  5. 9.3 Europe Molecular Diagnostics Tests & Reagents Revenue Share by Type (2021-2032)
  6. 9.4 Europe Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2032)
  7. 9.4.1 Europe Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2026)
  8. 9.4.2 Europe Molecular Diagnostics Tests & Reagents Revenue by Application (2027-2032)
  9. 9.5 Europe Molecular Diagnostics Tests & Reagents Revenue Share by Application (2021-2032)
  10. 9.6 Europe Molecular Diagnostics Tests & Reagents Revenue by Country
  11. 9.6.1 Europe Molecular Diagnostics Tests & Reagents Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Molecular Diagnostics Tests & Reagents Revenue by Country (2021-2026)
  13. 9.6.3 Europe Molecular Diagnostics Tests & Reagents Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Molecular Diagnostics Tests & Reagents Revenue (2021-2032)
  2. 10.2 China Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2032)
  3. 10.2.1 China Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2026)
  4. 10.2.2 China Molecular Diagnostics Tests & Reagents Revenue by Type (2027-2032)
  5. 10.3 China Molecular Diagnostics Tests & Reagents Revenue Share by Type (2021-2032)
  6. 10.4 China Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2032)
  7. 10.4.1 China Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2026)
  8. 10.4.2 China Molecular Diagnostics Tests & Reagents Revenue by Application (2027-2032)
  9. 10.5 China Molecular Diagnostics Tests & Reagents Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Molecular Diagnostics Tests & Reagents Revenue (2021-2032)
  2. 11.2 Asia Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2032)
  3. 11.2.1 Asia Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2026)
  4. 11.2.2 Asia Molecular Diagnostics Tests & Reagents Revenue by Type (2027-2032)
  5. 11.3 Asia Molecular Diagnostics Tests & Reagents Revenue Share by Type (2021-2032)
  6. 11.4 Asia Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2032)
  7. 11.4.1 Asia Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2026)
  8. 11.4.2 Asia Molecular Diagnostics Tests & Reagents Revenue by Application (2027-2032)
  9. 11.5 Asia Molecular Diagnostics Tests & Reagents Revenue Share by Application (2021-2032)
  10. 11.6 Asia Molecular Diagnostics Tests & Reagents Revenue by Country
  11. 11.6.1 Asia Molecular Diagnostics Tests & Reagents Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Molecular Diagnostics Tests & Reagents Revenue by Country (2021-2026)
  13. 11.6.3 Asia Molecular Diagnostics Tests & Reagents Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Molecular Diagnostics Tests & Reagents Revenue (2021-2032)
  2. 12.2 SAMEA Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Molecular Diagnostics Tests & Reagents Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Molecular Diagnostics Tests & Reagents Revenue by Type (2027-2032)
  5. 12.3 SAMEA Molecular Diagnostics Tests & Reagents Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Molecular Diagnostics Tests & Reagents Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Molecular Diagnostics Tests & Reagents Revenue by Application (2027-2032)
  9. 12.5 SAMEA Molecular Diagnostics Tests & Reagents Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Molecular Diagnostics Tests & Reagents Revenue by Country
  11. 12.6.1 SAMEA Molecular Diagnostics Tests & Reagents Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Molecular Diagnostics Tests & Reagents Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Molecular Diagnostics Tests & Reagents Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst